Skip to main content

CORRECTION article

Front. Psychiatry, 06 July 2022
Sec. Mood Disorders

Corrigendum: Isobaric Tags for Relative and Absolute Quantitation Identification of Blood Proteins Relevant to Paroxetine Response in Patients With Major Depressive Disorder

\nChin-Chuen LinChin-Chuen Lin1Hung SuHung Su2Jentaie ShieaJentaie Shiea2Tiao-Lai Huang,
Tiao-Lai Huang1,3*
  • 1Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan
  • 2Department of Chemistry, National Sun Yat-Sen University, Kaohsiung, Taiwan
  • 3Genomic and Proteomic Core Laboratory, Department of Medical Research, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan

In the original article, there was an error. A typo was present in the IRB number. A correction has been made to Materials and Methods, “Study Samples,” paragraph one.

“The institutional review board (IRB) of Chang Gung Memorial Hospital approved the study design (IRB number 201501596B0)” has been corrected to “The institutional review board (IRB) of Chang Gung Memorial Hospital approved the study design (IRB number 201601596B0).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: eukaryotic translation initiation factor 4H (eIF4H), iTRAQ, major depressive disorder, putative hydroxypyruvate isomerase (HYI), RNA binding motif 8A (RBM8A)

Citation: Lin C-C, Su H, Shiea J and Huang T-L (2022) Corrigendum: Isobaric Tags for Relative and Absolute Quantitation Identification of Blood Proteins Relevant to Paroxetine Response in Patients With Major Depressive Disorder. Front. Psychiatry 13:937238. doi: 10.3389/fpsyt.2022.937238

Received: 06 May 2022; Accepted: 13 June 2022;
Published: 06 July 2022.

Edited and reviewed by: Reiji Yoshimura, University of Occupational and Environmental Health, Japan

Copyright © 2022 Lin, Su, Shiea and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Tiao-Lai Huang, a540520@adm.cgmh.org.tw

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.